Pelthos Therapeutics PTHS
NYSE PTHS
$9.34 +0.44 (+4.94%)
As of: Nov 11, 2026 · 3:59 PM EST

Pelthos Therapeutics (PTHS) Asset Writedowns and Impairment (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported Asset Writedowns and Impairment of $925,000 for Q2 2026.

Analysis

Pelthos Therapeutics (PTHS) Asset Writedowns and Impairment (2025 - 2026) Analysis & Trends

For FY2025, Pelthos Therapeutics posted Asset Writedowns and Impairment of $1.06 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pelthos Therapeutics 33.36 Mn -55.04 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 925,000.00
Dec 31, 2025 263,000.00
Sep 30, 2025 792,000.00
API Access

Pelthos Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PTHS&period=max&api_key=YOUR_API_KEY